Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Julie Kim
Pharma
Takeda wins FDA nod for first-in-class blood cancer drug Mimrylo
One of three key launches for Takeda's next phase of growth, Mimrylo is the first drug for polycythemia vera that mimics hepcidin.
Angus Liu
Aug 28, 2026 10:04pm
Takeda's $1.3B savings drive to impact 4,500 roles in '26
May 13, 2026 11:41am
Takeda looks to put generic Vyvanse woes in the rearview
Jan 29, 2026 1:21pm
With Weber retiring in 2026, Takeda names Kim as its next CEO
Jan 30, 2025 9:35am
AAPI month: Julie Kim of Takeda US
May 9, 2023 7:10am
Takeda makes a group of executive promotions, unveils Q3 results
Feb 3, 2022 11:00am
